Pozen’s Wagon is Tied to Horizon and Sanofi
moreView todays social media effects on POZNView the latest stocks trending across Twitter. Click to view dashboardSee who Pozen is hiring next, click here to view […]
POZN
PropThink: Can Patients Scoop Clinical Trial Results?
[ACN Newswire] – By Jason Napodano, CFAIn the age of the Internet and social media portals such as Facebook and Twitter, investors are turning more and more to non-conventional sources of information to gain an advantage … moreView todays social media effects on POZNView the latest stocks trending across Twitter. Click to view dashboard […]
PropThink: Pozen Presents Impressive Phase 3 Data At ACG
[ACN Newswire] – By Jason Napodano, CFAOn October 22, 2012, Pozen (NASDAQ:POZN) presented a full analysis of the integrated results of its two Phase 3 studies comparing PA-325/40 (EC-ASA 325 mg + IR omeprazole 40 mg) to … moreView todays social media effects on POZNView the latest stocks trending across Twitter. Click to view dashboard […]
